Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Understanding the Potential Role and Delivery Approaches of Nitric Oxide in Chronic Wound Healing Management

Author(s): Mimansa Kandhwal, Tapan Behl*, Arun Kumar and Sandeep Arora

Volume 27, Issue 17, 2021

Published on: 26 October, 2020

Page: [1999 - 2014] Pages: 16

DOI: 10.2174/1381612826666201026152209

Price: $65

Abstract

Nitric oxide (NO) is a promising pharmaceutical component that has vasodilator, anti-bacterial, and wound healing activities. Chronic ulcers are non-healing disorders that are generally associated with distortion of lower limbs. Among the severe consequence derivatives of these diseases are the problems of chronic wound progression. NO, which is categorized as the smallest gaseous neurotransmitter, has beneficial effects in different phases of chronic inflammation. The defensive mechanism of NO is found useful in several severe conditions, such as gestational healing, gastrointestinal healing, and diabetic healing. The current review presents an updated collection of literature about the role of NO in chronic ulcers due to the prevalence of diabetes, DPN, and diabetic foot ulcers, and because of the lack of available effective treatments to directly address the pathology contributing to these conditions, novel treatments are being sought. This review also collects information about deficiency of NO synthase in diabetic patients, leading to a lack of vascularization of the peripheral nerves, which causes diabetic neuropathy, and this could be treated with vasodilators such as nitric oxide. Apart from the pharmacological mechanism of NO, the article also reviewed and analyzed to elucidate the potential of transdermal delivery of NO for the treatment of chronic ulcers.

Keywords: Nitric oxide, nanoparticles, antimicrobial, biopolymers, wound healing, ulcers.

« Previous Next »
[1]
Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997; 99(12): 2818-25.
[http://dx.doi.org/10.1172/JCI119473] [PMID: 9185502]
[2]
Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V. Nitric oxide and its implications in skin homeostasis and disease - a review. Arch Dermatol Res 1998; 290(12): 643-51.
[http://dx.doi.org/10.1007/s004030050367] [PMID: 9879832]
[3]
Wink DA, Mitchell JB. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998; 25(4-5): 434-56.
[http://dx.doi.org/10.1016/S0891-5849(98)00092-6] [PMID: 9741580]
[4]
Zacharia IG, Deen WM. Diffusivity and solubility of nitric oxide in water and saline. Ann Biomed Eng 2005; 33(2): 214-22.
[http://dx.doi.org/10.1007/s10439-005-8980-9] [PMID: 15771275]
[5]
Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43(2): 109-42.
[PMID: 1852778]
[6]
Saraiva J, Marotta-Oliveira SS, Cicillini SA, Eloy JdeO, Marchetti JM. Nanocarriers for nitric oxide delivery. J Drug Deliv 2011; 2011: 936438.
[http://dx.doi.org/10.1155/2011/936438] [PMID: 21869934]
[7]
Lancaster JR Jr. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1997; 1(1): 18-30.
[http://dx.doi.org/10.1006/niox.1996.0112] [PMID: 9701041]
[8]
Kumar A, Kaur H. Sprayed in-situ synthesis of polyvinyl alcohol/chitosan loaded silver nanocomposite hydrogel for improved antibacterial effects. Int J Biol Macromol 2020; 145: 950-64.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.09.186] [PMID: 31669274]
[9]
Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341(10): 738-46.
[http://dx.doi.org/10.1056/NEJM199909023411006] [PMID: 10471461]
[10]
Tymvios C, Moore C, Jones S, Solomon A, Sanz-Rosa D, Emerson M. Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase. Br J Pharmacol 2009; 158(7): 1735-42.
[http://dx.doi.org/10.1111/j.1476-5381.2009.00408.x] [PMID: 19912226]
[11]
Rizk M, Witte MB, Barbul A. Nitric oxide and wound healing. World J Surg 2004; 28(3): 301-6.
[http://dx.doi.org/10.1007/s00268-003-7396-7] [PMID: 14961192]
[12]
Greer N, Foman N, Dorrian J, et al. Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers: a systematic review. Ann Intern Med 2012; 159(8): 532-42.
[13]
Patil S, Reddy SN, Maheshwari S, Khandelwal S, Shruthi D, Doni B. Prevalence of recurrent aphthous ulceration in the Indian Population. J Clin Exp Dent 2014; 6(1): e36-40.
[http://dx.doi.org/10.4317/jced.51227] [PMID: 24596633]
[14]
Suresh DH, Suryanarayan S, Sarvajnamurthy S, Puvvadi S. Treatment of a non-healing diabetic foot ulcer with platelet-rich plasma. J Cutan Aesthet Surg 2014; 7(4): 229-31.
[http://dx.doi.org/10.4103/0974-2077.150786] [PMID: 25722604]
[15]
Arun K. Tapan Behl, Swati Chadha. Synthesis of physically crosslinked PVA/Chitosan loaded silver nanoparticles hydrogels with tunable mechanical properties and antibacterial effects. Int J Biol Macromol 2020; 145: 1262-74.
[16]
Miller MR, Megson IL. Recent developments in nitric oxide donor drugs. Br J Pharmacol 2007; 151(3): 305-21.
[http://dx.doi.org/10.1038/sj.bjp.0707224] [PMID: 17401442]
[17]
Wu J, Li F, Hu X, et al. Responsive assembly of silver nanoclusters with a biofilm locally amplified bactericidal effect to enhance treatments against multi-drug-resistant bacterial infections. ACS Cent Sci 2019; 5(8): 1366-76.
[http://dx.doi.org/10.1021/acscentsci.9b00359] [PMID: 31482119]
[18]
Arun K. Maneesh Jaiswal. Design and in-vitro investigation of nanocomposite hydrogel based in-situ spray dressing for chronic wounds and synthesis of silver nanoparticles using green chemistry. J Appl Polym Sci 2016; 133: 43260.
[19]
Chen F, Xia Q, Ju LK. Competition between oxygen and nitrate respirations in continuous culture of Pseudomonas aeruginosa performing aerobic denitrification. Biotechnol Bioeng 2006; 93(6): 1069-78.
[http://dx.doi.org/10.1002/bit.20812] [PMID: 16435399]
[20]
Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284(5418): 1318-22.
[http://dx.doi.org/10.1126/science.284.5418.1318] [PMID: 10334980]
[21]
Bauer JA. Hydroxocobalamins as biologically compatible donors of nitric oxide implicated in the acceleration of wound healing. Med Hypotheses 1998; 51(1): 65-7.
[http://dx.doi.org/10.1016/S0306-9877(98)90256-0] [PMID: 9881839]
[22]
Arun K. Tapan Behl, Swati Chadha. A rationalized and innovative perspective of nanotechnology and nanobiotechnology in chronic wound management. J Dru Del Sci Tech 2020; 60: 101930.
[http://dx.doi.org/10.1016/j.jddst.2020.101930]
[23]
Stechmiller JK, Childress B, Cowan L. Arginine supplementation and wound healing. Nutr Clin Pract 2005; 20(1): 52-61.
[http://dx.doi.org/10.1177/011542650502000152] [PMID: 16207646]
[24]
Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83(3): 835-70.
[http://dx.doi.org/10.1152/physrev.2003.83.3.835] [PMID: 12843410]
[25]
Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 2005; 31(6): 674-86.
[http://dx.doi.org/10.1097/00042728-200506000-00011] [PMID: 15996419]
[26]
Shearer J, Richards J, Mills C, Caldwell M. Differential regulation of macrophage L -arginine metabolism: a proposed role in wound healing. Am Physiol Soc 1997; 272: 181-90.
[http://dx.doi.org/10.1152/ajpendo.1997.272.2.E181]
[27]
Curran JN, Winter DC, Bouchier-Hayes D. Biological fate and clinical implications of arginine metabolism in tissue healing. Wound Repair Regen 2006; 14(4): 376-86.
[http://dx.doi.org/10.1111/j.1743-6109.2006.00151.x] [PMID: 16939563]
[28]
Young A, McNaught C. The physiology of wound healing. Surgery 2011; 29: 475-9.
[29]
Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol 2007; 25(1): 9-18.
[http://dx.doi.org/10.1016/j.clindermatol.2006.09.007] [PMID: 17276196]
[30]
McCarty SM, Percival SL. Proteases and delayed wound healing. Adv Wound Care (New Rochelle) 2013; 2(8): 438-47.
[http://dx.doi.org/10.1089/wound.2012.0370] [PMID: 24688830]
[31]
Schreml S, Szeimies RM, Prantl L, Karrer S, Landthaler M, Babilas P. Oxygen in acute and chronic wound healing. Br J Dermatol 2010; 163(2): 257-68.
[http://dx.doi.org/10.1111/j.1365-2133.2010.09804.x] [PMID: 20394633]
[32]
Dhall S, Do DC, Garcia M, et al. Generating and reversing chronic wounds in diabetic mice by manipulating wound redox parameters. J Diabetes Res 2014; 2014: 562625.
[http://dx.doi.org/10.1155/2014/562625] [PMID: 25587545]
[33]
Tsourdi E, Barthel A, Rietzsch H, Reichel A, Bornstein SR. Current aspects in the pathophysiology and treatment of chronic wounds in diabetes mellitus. BioMed Res Int 2013; 2013: 385641.
[http://dx.doi.org/10.1155/2013/385641] [PMID: 23653894]
[34]
Stanley A, Osler T. Senescence and the healing rates of venous ulcers. J Vasc Surg 2001; 33(6): 1206-11.
[http://dx.doi.org/10.1067/mva.2001.115379] [PMID: 11389419]
[35]
Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45(7): 1011-6.
[http://dx.doi.org/10.1007/s00125-002-0868-8] [PMID: 12136400]
[36]
Tsioufis C, Bafakis I, Kasiakogias A, Stefanadis C. The role of matrix metalloproteinases in diabetes mellitus. Curr Top Med Chem 2012; 12(10): 1159-65.
[http://dx.doi.org/10.2174/1568026611208011159] [PMID: 22519446]
[37]
Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376(24): 2367-75.
[http://dx.doi.org/10.1056/NEJMra1615439] [PMID: 28614678]
[38]
Walsh JW, Hoffstad OJ, Sullivan MO, Margolis DJ. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med 2016; 33(11): 1493-8.
[http://dx.doi.org/10.1111/dme.13054] [PMID: 26666583]
[39]
Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005; 366(9498): 1736-43.
[http://dx.doi.org/10.1016/S0140-6736(05)67700-8] [PMID: 16291068]
[40]
Kirsner RS, Warriner R, Michela M, Stasik L, Freeman K. Advanced biological therapies for diabetic foot ulcers. Arch Dermatol 2010; 146(8): 857-62.
[http://dx.doi.org/10.1001/archdermatol.2010.164] [PMID: 20713816]
[41]
Leung PC. Diabetic foot ulcers--a comprehensive review. Surgeon 2007; 5(4): 219-31.
[http://dx.doi.org/10.1016/S1479-666X(07)80007-2] [PMID: 17849958]
[42]
Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996; 334(19): 1209-15.
[43]
Erinjeri JP, Fong AJ, Kemeny NE, Brown KT, Getrajdman GI, Solomon SB. Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement. Cancer 2011; 117(6): 1296-301.
[http://dx.doi.org/10.1002/cncr.25573] [PMID: 21381016]
[44]
Mendelsohn FA, Divino CM, Reis ED, Kerstein MD. Wound care after radiation therapy. Adv Skin Wound Care 2002; 15(5): 216-24.
[http://dx.doi.org/10.1097/00129334-200209000-00007] [PMID: 12368711]
[45]
Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol 2010; 8(9): 623-33.
[http://dx.doi.org/10.1038/nrmicro2415] [PMID: 20676145]
[46]
Martellet MC, Martins A, Marmitt DJ, Schneider T, Contini V, Goettert MI. New opportunities for the application of natural products based on nitric oxide modulation: From research to registered patents. Studies in Natural Products Chemistry 2020; p. 65.
[47]
Zhou L, Zhu DY. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 2009; 20(4): 223-30.
[http://dx.doi.org/10.1016/j.niox.2009.03.001] [PMID: 19298861]
[48]
Izumi Y, Clifford DB, Zorumski CF. Inhibition of long-term potentiation by NMDA-mediated nitric oxide release. Science 1992; 257(5074): 1273-6.
[http://dx.doi.org/10.1126/science.1519065] [PMID: 1519065]
[49]
Izumi Y, Zorumski CF. Nitric oxide and long-term synaptic depression in the rat hippocampus. Neuroreport 1993; 4(9): 1131-4.
[PMID: 8219040]
[50]
Forstermann U. Regulation of nitric oxide synthase expression and activity. Nitric Oxide. Handbook of Experimental PharmacologyBerlin: Springer 2000.
[http://dx.doi.org/10.1007/978-3-642-57077-3_4]
[51]
Förstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994; 23(6 Pt 2): 1121-31.
[http://dx.doi.org/10.1161/01.HYP.23.6.1121] [PMID: 7515853]
[52]
Steinert JR, Chernova T, Forsythe ID. Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist 2010; 16(4): 435-52.
[http://dx.doi.org/10.1177/1073858410366481] [PMID: 20817920]
[53]
Nathan CF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3(1): 65-70.
[http://dx.doi.org/10.1016/0952-7915(91)90079-G] [PMID: 1711326]
[54]
Langrehr JM, Hoffman RA, Billiar TR, Lee KK, Schraut WH, Simmons RL. Nitric oxide synthesis in the in vivo allograft response: a possible regulatory mechanism. Surgery 1991; 110(2): 335-42.
[PMID: 1858041]
[55]
Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87(1): 315-424.
[http://dx.doi.org/10.1152/physrev.00029.2006] [PMID: 17237348]
[56]
Fehsel K, Jalowy A, Qi S, Burkart V, Hartmann B, Kolb H. Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 1993; 42(3): 496-500.
[http://dx.doi.org/10.2337/diab.42.3.496] [PMID: 8432420]
[57]
Li LM, Kilbourn RG, Adams J, Fidler IJ. Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 1991; 51(10): 2531-5.
[PMID: 1902393]
[58]
Green SJ, Mellouk S, Hoffman SL, Meltzer MS, Nacy CA. Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogen oxides from L-arginine by macrophages and hepatocytes. Immunol Lett 1990; 25(1-3): 15-9.
[http://dx.doi.org/10.1016/0165-2478(90)90083-3] [PMID: 2126524]
[59]
Kröncke KD, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun 1991; 175(3): 752-8.
[http://dx.doi.org/10.1016/0006-291X(91)91630-U] [PMID: 2025250]
[60]
Qidwai T, Jamal F. Inducible nitric oxide synthase (iNOS) gene polymorphism and disease prevalence. Scand J Immunol 2010; 72(5): 375-87.
[http://dx.doi.org/10.1111/j.1365-3083.2010.02458.x] [PMID: 21039732]
[61]
Shen Y, Lee YS, Soelaiman S, et al. Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins. EMBO J 2002; 21(24): 6721-32.
[http://dx.doi.org/10.1093/emboj/cdf681] [PMID: 12485993]
[62]
Pritchard KA Jr, Ackerman AW, Gross ER, et al. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 2001; 276(21): 17621-4.
[http://dx.doi.org/10.1074/jbc.C100084200] [PMID: 11278264]
[63]
Song Y, Cardounel AJ, Zweier JL, Xia Y. Inhibition of superoxide generation from neuronal nitric oxide synthase by heat shock protein 90: implications in NOS regulation. Biochemistry 2002; 41(34): 10616-22.
[http://dx.doi.org/10.1021/bi026060u] [PMID: 12186546]
[64]
Sowa G, Pypaert M, Sessa WC. Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci USA 2001; 98(24): 14072-7.
[http://dx.doi.org/10.1073/pnas.241409998] [PMID: 11707586]
[65]
Drab M, Verkade P, Elger M, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001; 293(5539): 2449-52.
[http://dx.doi.org/10.1126/science.1062688] [PMID: 11498544]
[66]
Park JE, Abrams MJ, Efron PA, Barbul A. Excessive nitric oxide impairs wound collagen accumulation. J Surg Res 2013; 183(1): 487-92.
[http://dx.doi.org/10.1016/j.jss.2012.11.056] [PMID: 23290597]
[67]
Forstermann U. Regulation of nitric oxide synthase expression and activity. Nitric Oxide. Handbook of Experimental Pharmacology Berlin: Springer 2000.
[http://dx.doi.org/10.1007/978-3-642-57077-3_4]
[68]
Luo JD, Chen AF. Nitric oxide: a newly discovered function on wound healing. Acta Pharmacol Sin 2005; 26(3): 259-64.
[http://dx.doi.org/10.1111/j.1745-7254.2005.00058.x] [PMID: 15715920]
[69]
Amadeu TP, Seabra AB, de Oliveira MG, Monte-Alto-Costa A. Nitric oxide donor improves healing if applied on inflammatory and proliferative phase. J Surg Res 2008; 149(1): 84-93.
[http://dx.doi.org/10.1016/j.jss.2007.10.015] [PMID: 18374944]
[70]
Witte MB, Barbul A. Role of nitric oxide in wound repair. Am J Surg 2002; 183(4): 406-12.
[http://dx.doi.org/10.1016/S0002-9610(02)00815-2] [PMID: 11975928]
[71]
Takeuchi K, Kato S, Takehara K, Asada Y, Yasuiro T. Role of nitric oxide in mucosal blood flow response and the healing of HCl-induced lesions in the rat stomach. Digestion 1997; 58(1): 19-27.
[http://dx.doi.org/10.1159/000201419] [PMID: 9018006]
[72]
Chen K, Inoue M, Wasa M, Fukuzawa M, Kamata S, Okada A. Expression of endothelial constitutive nitric oxide synthase mRNA in gastrointestinal mucosa and its downregulation by endotoxin. Life Sci 1997; 61(13): 1323-9.
[http://dx.doi.org/10.1016/S0024-3205(97)00677-2] [PMID: 9324074]
[73]
Tang Q, Zhang W, Zhang C, et al. Oxymatrine loaded nitric oxide-releasing liposomes for the treatment of ulcerative colitis. Int J Pharm 2020; 586: 119617.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119617] [PMID: 32650111]
[74]
Abaffy P, Tomankova S, Naraine R, Kubista M, Sindelka R. The role of nitric oxide during embryonic wound healing. BMC Genomics 2019; 20(1): 815.
[http://dx.doi.org/10.1186/s12864-019-6147-6] [PMID: 31694542]
[75]
Cao M, Westerhausen-Larson A, Niyibizi C, et al. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 1997; 324(Pt 1): 305-10.
[http://dx.doi.org/10.1042/bj3240305] [PMID: 9164871]
[76]
Ralston SH, Grabowski PS. Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins. Bone 1996; 19(1): 29-33.
[http://dx.doi.org/10.1016/8756-3282(96)00101-9] [PMID: 8830984]
[77]
Wimalawansa SJ. Targeting nitric oxide for bone disease. Encyclopedia of Bone Biology. 2020; pp. 666-96.
[78]
Gélinas DS, Bernatchez PN, Rollin S, Bazan NG, Sirois MG. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. Br J Pharmacol 2002; 137(7): 1021-30.
[http://dx.doi.org/10.1038/sj.bjp.0704956] [PMID: 12429574]
[79]
Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99(11): 2625-34.
[http://dx.doi.org/10.1172/JCI119451] [PMID: 9169492]
[80]
Ziche M, Morbidelli L, Masini E, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94(5): 2036-44.
[http://dx.doi.org/10.1172/JCI117557] [PMID: 7525653]
[81]
Malik AA, Radhakrishnan N, Reddy K, Smith AD, Singhal PC. Tubular cell-Escherichia coli interaction products modulate migration of monocytes through generation of transforming growth factor-beta and macrophage-monocyte chemoattractant protein-1. J Endourol 2002; 16(8): 599-603.
[http://dx.doi.org/10.1089/089277902320913305] [PMID: 12470469]
[82]
Dhaunsi GS, Ozand PT. Nitric oxide promotes mitogen-induced DNA synthesis in human dermal fibroblasts through cGMP. Clin Exp Pharmacol Physiol 2004; 31(1-2): 46-9.
[http://dx.doi.org/10.1111/j.1440-1681.2004.03948.x] [PMID: 14756683]
[83]
Frank S, Kämpfer H, Wetzler C, Pfeilschifter J. Nitric oxide drives skin repair: novel functions of an established mediator. Kidney Int 2002; 61(3): 882-8.
[http://dx.doi.org/10.1046/j.1523-1755.2002.00237.x] [PMID: 11849442]
[84]
Schäffer MR, Efron PA, Thornton FJ, Klingel K, Gross SS, Barbul A. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol 1997; 158(5): 2375-81.
[PMID: 9036987]
[85]
Schwentker A, Vodovotz Y, Weller R, Billiar TR. Nitric oxide and wound repair: role of cytokines? Nitric Oxide 2002; 7(1): 1-10.
[http://dx.doi.org/10.1016/S1089-8603(02)00002-2] [PMID: 12175813]
[86]
Friedman AJ, Han G, Navati MS, et al. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 2008; 19(1): 12-20.
[http://dx.doi.org/10.1016/j.niox.2008.04.003] [PMID: 18457680]
[87]
Marshall WF, Young KD, Swaffer M, et al. What determines cell size? BMC Biol 2012; 10: 101.
[http://dx.doi.org/10.1186/1741-7007-10-101] [PMID: 23241366]
[88]
Subczynski WK, Lomnicka M, Hyde JS. Permeability of nitric oxide through lipid bilayer membranes. Free Radic Res 1996; 24(5): 343-9.
[http://dx.doi.org/10.3109/10715769609088032] [PMID: 8733938]
[89]
Weller R. Nitric oxide: a key mediator in cutaneous physiology. Clin Exp Dermatol 2003; 28(5): 511-4.
[http://dx.doi.org/10.1046/j.1365-2230.2003.01365.x] [PMID: 12950342]
[90]
Ghaffari A, Jalili R, Ghaffari M, Miller C, Ghahary A. Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections. Wound Repair Regen 2007; 15(3): 368-77.
[http://dx.doi.org/10.1111/j.1524-475X.2007.00239.x] [PMID: 17537124]
[91]
Keefer LK. Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities. Curr Top Med Chem 2005; 5(7): 625-36.
[http://dx.doi.org/10.2174/1568026054679380] [PMID: 16101424]
[92]
Kevil CG, Patel RP. S-Nitrosothiol biology and therapeutic potential in metabolic disease. Curr Opin Investig Drugs 2010; 11(10): 1127-34.
[PMID: 20872315]
[93]
Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004; 2(10): 820-32.
[http://dx.doi.org/10.1038/nrmicro1004] [PMID: 15378046]
[94]
Combet E, Paterson S, Iijima K, et al. Fat transforms ascorbic acid from inhibiting to promoting acid-catalysed N-nitrosation. Gut 2007; 56(12): 1678-84.
[http://dx.doi.org/10.1136/gut.2007.128587] [PMID: 17785370]
[95]
Bernal-Chávez S, Nava-Arzaluz MG, Quiroz-Segoviano RIY, Ganem-Rondero A. Nanocarrier-based systems for wound healing. Drug Dev Ind Pharm 2019; 45(9): 1389-402.
[http://dx.doi.org/10.1080/03639045.2019.1620270] [PMID: 31099263]
[96]
Lin PC, Lin S, Wang PC, Sridhar R. Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv 2014; 32(4): 711-26.
[http://dx.doi.org/10.1016/j.biotechadv.2013.11.006] [PMID: 24252561]
[97]
George S, Lin S, Ji Z, et al. Surface defects on plate-shaped silver nanoparticles contribute to its hazard potential in a fish gill cell line and zebrafish embryos. ACS Nano 2012; 6(5): 3745-59.
[http://dx.doi.org/10.1021/nn204671v] [PMID: 22482460]
[98]
Cortivo R, Vindigni V, Iacobellis L, Abatangelo G, Pinton P, Zavan B. Nanoscale particle therapies for wounds and ulcers. Nanomedicine (Lond) 2010; 5(4): 641-56.
[http://dx.doi.org/10.2217/nnm.10.32] [PMID: 20528458]
[99]
Hetrick EM, Shin JH, Stasko NA, et al. Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. ACS Nano 2008; 2(2): 235-46.
[http://dx.doi.org/10.1021/nn700191f] [PMID: 19206623]
[100]
Weller RB. Nitric oxide-containing nanoparticles as an antimicrobial agent and enhancer of wound healing. J Invest Dermatol 2009; 129(10): 2335-7.
[http://dx.doi.org/10.1038/jid.2009.149] [PMID: 19749782]
[101]
Martinez LR, Han G, Chacko M, et al. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J Invest Dermatol 2009; 129(10): 2463-9.
[http://dx.doi.org/10.1038/jid.2009.95] [PMID: 19387479]
[102]
Han G, Martinez LR, Mihu MR, Friedman AJ, Friedman JM, Nosanchuk JD. Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection. PLoS One 2009; 4(11): e7804.
[http://dx.doi.org/10.1371/journal.pone.0007804] [PMID: 19915659]
[103]
Mihu MR, Sandkovsky U, Han G, Friedman JM, Nosanchuk JD, Martinez LR. The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections. Virulence 2010; 1(2): 62-7.
[http://dx.doi.org/10.4161/viru.1.2.10038] [PMID: 21178416]
[104]
Han G, Nguyen LN, Macherla C, et al. Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition. Am J Pathol 2012; 180(4): 1465-73.
[http://dx.doi.org/10.1016/j.ajpath.2011.12.013] [PMID: 22306734]
[105]
Blecher K, Martinez LR, Tuckman-Vernon C, et al. Nitric oxide-releasing nanoparticles accelerate wound healing in NOD-SCID mice. Nanomedicine (Lond) 2012; 8(8): 1364-71.
[http://dx.doi.org/10.1016/j.nano.2012.02.014] [PMID: 22406184]
[106]
Friedman AJ, Blecher K, Schairer D, et al. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione. Nitric Oxide 2011; 25(4): 381-6.
[http://dx.doi.org/10.1016/j.niox.2011.09.001] [PMID: 21946032]
[107]
Cabrales P, Han G, Nacharaju P, Friedman AJ, Friedman JM. Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide. Am J Physiol Heart Circ Physiol 2011; 300(1): H49-56.
[http://dx.doi.org/10.1152/ajpheart.00665.2010] [PMID: 21057038]
[108]
Seabra AB, Rolim WR, Pieretti JC. Potent application of nitric oxide–releasing nanomaterials against toxigenic fungi and their mycotoxins. Nanomycotoxicology Treating Mycotoxins in the Nano Way 2020; pp. 481-501.
[http://dx.doi.org/10.1016/B978-0-12-817998-7.00020-3]
[109]
Weller CD, Team V, Sussman G. First line wound dressing update: A comprehensive review of the evidence. Front Pharmacol 2020; 11: 155.
[http://dx.doi.org/10.3389/fphar.2020.00155] [PMID: 32180720]
[110]
Wang CH, Hsieh DJ, Periasamy S, et al. Regenerative porcine dermal collagen matrix developed by supercritical carbon dioxide extraction technology: Role in accelerated wound healing. Materialia 2020; 9: 100576.
[http://dx.doi.org/10.1016/j.mtla.2019.100576]
[111]
Bagheri Miyab K, Alipoor E, Vaghardoost R, et al. The effect of a hydrolyzed collagen-based supplement on wound healing in patients with burn: A randomized double-blind pilot clinical trial. Burns 2020; 46(1): 156-63.
[http://dx.doi.org/10.1016/j.burns.2019.02.015] [PMID: 31859087]
[112]
Liu H, Zhu X, Guo H, et al. Nitric oxide released injectable hydrogel combined with synergistic photothermal therapy for antibacterial and accelerated wound healing. Applied Materialstoday 2020; 20: 100781.
[113]
Jones ML, Ganopolsky JG, Labbé A, Prakash S. A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis. Appl Microbiol Biotechnol 2010; 87(2): 509-16.
[http://dx.doi.org/10.1007/s00253-010-2490-x] [PMID: 20300748]
[114]
Jones M, Ganopolsky JG, Labbé A, et al. Novel nitric oxide producing probiotic wound healing patch: preparation and in vivo analysis in a New Zealand white rabbit model of ischaemic and infected wounds. Int Wound J 2012; 9(3): 330-43.
[http://dx.doi.org/10.1111/j.1742-481X.2011.00889.x] [PMID: 22221913]
[115]
Weller R, Finnen MJ. The effects of topical treatment with acidified nitrite on wound healing in normal and diabetic mice. Nitric Oxide 2006; 15(4): 395-9.
[http://dx.doi.org/10.1016/j.niox.2006.04.002] [PMID: 16731016]
[116]
Perez-Dıaz M, Alvarado-Gomez E, Magana-Aquino M, et al. Anti-biofilm activity of chitosan gels formulated with silver nanoparticles and their cytotoxic effect of human fibroblasts. Mat Sci Eng C Mater Biol Appl 2016; 60: 317-23.
[117]
Lee J, Kim J, Go J, et al. Transdermal treatment of the surgical and burned wound skin via phytochemical-capped gold nanoparticles. Colloids Surf B Biointerfaces 2015; 135: 166-74.
[http://dx.doi.org/10.1016/j.colsurfb.2015.07.058] [PMID: 26263209]
[118]
Mugade M, Patole M, Pokharkar V. Bioengineered mannan sulphate capped silver nanoparticles for accelerated and targeted wound healing: Physicochemical and biological investigations. Biomed Pharmacother 2017; 91: 95-110.
[http://dx.doi.org/10.1016/j.biopha.2017.04.017] [PMID: 28448875]
[119]
Croisier F. 2013. Chitosan-based biomaterials for tissue engineering. Eur Polym J 2013; 49: 780-92.
[http://dx.doi.org/10.1016/j.eurpolymj.2012.12.009]
[120]
Bonferoni MC, Sandri G, Dellera E, et al. Ionic polymeric micelles based on chitosan and fatty acids and intended for wound healing. Comparison of linoleic and oleic acid. Eur J Pharm Biopharm 2014; 87(1): 101-6.
[http://dx.doi.org/10.1016/j.ejpb.2013.12.018] [PMID: 24384070]
[121]
Muzzarelli A. Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydr Polym 2009; 76: 167-82.
[http://dx.doi.org/10.1016/j.carbpol.2008.11.002]
[122]
Ji H, Sun H, Qu X. Antibacterial applications of graphene-based nanomaterials: Recent achievements and challenges. Adv Drug Deliv Rev 2016; 105(Pt B): 176-89.
[http://dx.doi.org/10.1016/j.addr.2016.04.009] [PMID: 27129441]
[123]
Choi M, Hasan N, Cao J, Lee J, Hlaing SP, Yoo JW. Chitosan-based nitric oxide-releasing dressing for anti-biofilm and in vivo healing activities in MRSA biofilm-infected wounds. Int J Biol Macromol 2020; 142: 680-92.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.10.009] [PMID: 31622708]
[124]
Lowe A, Deng W, Smith DW Jr, Balkus KJ Jr. Acrylonitrile-based nitric oxide releasing melt-spun fibers for enhanced wound healing. Macromolecules 2012; 45: 5894-900.
[http://dx.doi.org/10.1021/ma300913w]
[125]
Lowe A, Deng W, Smith DW Jr, Balkus KJ Jr. Coated melt-spun acrylonitrile-based suture for delayed release of nitric oxide. Mater Lett 2014; 125: 221-3.
[http://dx.doi.org/10.1016/j.matlet.2014.03.174]
[126]
Neidrauer M, Ercan UK, Bhattacharyya A, et al. Antimicrobial efficacy and wound-healing property of a topical ointment containing nitric-oxide-loaded zeolites. J Med Microbiol 2014; 63(Pt 2): 203-9.
[http://dx.doi.org/10.1099/jmm.0.067322-0] [PMID: 24196133]

Rights & Permissions Print Cite
Article Metrics
67
1
1
© 2024 Bentham Science Publishers | Privacy Policy